BYSI
BeyondSpring IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$72.38M
P/E Ratio
—
EPS
$-0.21
Beta
0.51
52W High
$3.44
52W Low
$1.03
50-Day MA
$1.52
200-Day MA
$1.84
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
10.54
PEG Ratio
0.00
About BeyondSpring Inc
BeyondSpring Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology cancer therapies. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $1.88M |
| Gross Profit (TTM) | $1.35M |
| EBITDA | $-8.86M |
| Operating Margin | 0.00% |
| Return on Equity | -310.50% |
| Return on Assets | -18.60% |
| Revenue/Share (TTM) | $0.05 |
| Book Value | $-0.80 |
| Price-to-Book | 5.38 |
| Price-to-Sales (TTM) | 45.99 |
| EV/Revenue | 41.79 |
| EV/EBITDA | 0.05 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 14.30% |
| Shares Outstanding | $41.12M |
| Float | $31.69M |
| % Insiders | 14.96% |
| % Institutions | 14.56% |
Historical Volatility
HV 10-Day
38.35%
HV 20-Day
67.83%
HV 30-Day
69.35%
HV 60-Day
60.56%
HV Rank
33.3%
Volatility is currently contracting
Data last updated: 4/9/2026